Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management—a joint position paper of the European Society of CardiologyWorking Group on Cardiovascular Pharmacotherapy and European Society of CardiologyWorking Group on Thrombosis [PDF]
Agewall, Stefan +15 more
core +1 more source
How Should Canadian Pharmacy Departments Utilize Idarucizumab?
Kirsten Tangedal +2 more
openalex +2 more sources
Dabigatran overload in acute kidney injury: haemodialysis or idarucizumab? A case report and proposal for a decisional algorithm [PDF]
Andrea Galassi +5 more
openalex +1 more source
Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal [PDF]
core +1 more source
Idarucizumab Dosing in Kidney Failure [PDF]
Luke Yip, Jou-Fang Deng
openaire +2 more sources
Idarucizumab hebt die Wirkung des direkten Thrombininhibitors rasch auf [PDF]
Springer Medizin
openalex +1 more source

